PubRank

Wen-Ho Chang

Author PubWeight™ 13.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection. J Clin Psychopharmacol 2007 1.41
2 Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study. J Clin Psychiatry 2007 1.25
3 Risperidone-related weight gain: genetic and nongenetic predictors. J Clin Psychopharmacol 2006 1.02
4 Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults. J Psychiatry Neurosci 2008 0.97
5 Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene. Am J Psychiatry 2002 0.97
6 Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances. J Clin Psychiatry 2004 0.89
7 Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function. Int J Neuropsychopharmacol 2004 0.85
8 Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia. J Clin Psychiatry 2003 0.84
9 Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics. Pharmacogenomics 2005 0.83
10 Dopamine D3 receptor Ser9Gly polymorphism and risperidone response. J Clin Psychopharmacol 2005 0.79
11 Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia. J Clin Pharmacol 2004 0.78
12 Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders. Schizophr Res 2004 0.77
13 Regular-dose risperidone on QTc intervals. J Clin Psychopharmacol 2005 0.76
14 Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants. Psychopharmacology (Berl) 2003 0.75
15 Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study. J Clin Psychopharmacol 2002 0.75
16 Fluvoxamine-clozapine interaction: time-dependent? J Clin Psychopharmacol 2002 0.75
17 Time to rehospitalization in patients with bipolar I disorder on lithium or valproate with adjunctive antipsychotics. Psychopharmacology (Berl) 2008 0.75
18 Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects. J Clin Psychopharmacol 2002 0.75
19 Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics. J Clin Psychopharmacol 2002 0.75
20 Dosing strategies of clozapine-fluvoxamine cotreatment. J Clin Psychopharmacol 2002 0.75